BridgeBio Oncology Therapeutics, Inc. BBOT
1.81 USD -0.05 (-2.69%)
Regular-session close
1.81 0.00 0.00%
After hours · Nov 20, 4:00 PM ET
1.79 Day range 1.94
1.80 52-week range 13.69
- YTD
- -85.54%
- 1 year
- -85.14%
News
benzinga.com Why Gap Shares Are Trading Higher By Around 4%; Here Are 20 Stocks Moving Premarket Gap shares rise 3.8% after Q3 EPS beat estimates; Athleta names new CEO. Erayak and NewGenIvf lead gainers, Solmate leads losers.benzinga.com Morgan Stanley Maintains Overweight on BridgeBio Oncology, Lowers Price Target to $12 Morgan Stanley analyst Sean Laaman maintains BridgeBio Oncology (NASDAQ:BBOT) with a Overweight and lowers the price target from $13 to $12.
benzinga.com These Analysts Cut Their Forecasts On BridgeBio Oncology After Q3 Results BridgeBio Oncology beat Q3 loss estimates, shares jumped 18%, while analysts cut price targets to $9 and $15.benzinga.com Piper Sandler Maintains Overweight on BridgeBio Oncology, Lowers Price Target to $15 Piper Sandler analyst Biren Amin maintains BridgeBio Oncology (NASDAQ:BBOT) with a Overweight and lowers the price target from $21 to $15.
benzinga.com Wedbush Maintains Outperform on BridgeBio Oncology, Lowers Price Target to $9 Wedbush analyst David Nierengarten maintains BridgeBio Oncology (NASDAQ:BBOT) with a Outperform and lowers the price target from $25 to $9.
benzinga.com BridgeBio Oncology Q3 EPS $(0.43) Beats $(0.69) Estimate BridgeBio Oncology (NASDAQ:BBOT) reported quarterly losses of $(0.43) per share which beat the analyst consensus estimate of $(0.69) by 37.68 percent. This is a 58.25 percent increase over losses of…
